FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2570786987> ?p ?o ?g. }

• W2570786987 endingPage "808" @default.
• W2570786987 startingPage "807" @default.
• W2570786987 abstract "Atrial fibrillation (AF) frequently complicates the management of chronic kidney disease, especially in patients with end-stage renal disease (ESRD). AF occurs in approximately one in five of the 650 000 patients with ESRD in the USA.1 ESRD confers increased risk for AF, while AF hastens progression to ESRD. The presence of chronic kidney disease in patients with AF is associated with an increased risk for ischaemic stroke independent of traditional risk factors. In addition, chronic kidney disease and particularly ESRD are associated with an increased risk of bleeding.Little is understood about how to safely reduce the risk of thromboembolic events in patients with AF and ESRD. Prospective trials of AF have uniformly excluded patients with a glomerular filtration rate (GFR) <30 mL/hour. ESRD produces alterations in haemostasis that predispose patients to haemorrhagic (platelet α granule depletion, reduced endothelial cell adhesion molecule expression) and thrombotic (increased circulating fibrinogen) complications, limiting extrapolation of data from patients with normal renal function. Data on the net clinical effect of warfarin in patients with ESRD are limited to observational studies. Many experiences have suggested harm in the form of excess stroke and death, while others have suggested benefit (table 1).2–6 Reflecting uncertainty in the available body of evidence, Kidney Disease: Improving Global Outcomes (KDIGO) modified their 2011 consensus statement on cardiovascular disease to recommend against routine oral anticoagulation in dialysis patients with AF.1 In contrast, the most recent 2014 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Rhythm Society guidelines on AF provide a grade IIa recommendation for use of warfarin in ESRD.View this table:Table 1 Outcomes associated with warfarin therapy in …" @default.
• W2570786987 created "2017-01-13" @default.
• W2570786987 creator A5023346746 @default.
• W2570786987 creator A5059846687 @default.
• W2570786987 date "2017-01-09" @default.
• W2570786987 modified "2023-09-27" @default.
• W2570786987 title "Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?" @default.
• W2570786987 cites W1981440884 @default.
• W2570786987 cites W2024301885 @default.
• W2570786987 cites W2025282593 @default.
• W2570786987 cites W2054077136 @default.
• W2570786987 cites W2068657668 @default.
• W2570786987 cites W2073789348 @default.
• W2570786987 cites W2100505398 @default.
• W2570786987 cites W2123257771 @default.
• W2570786987 cites W2137138584 @default.
• W2570786987 cites W2519365725 @default.
• W2570786987 doi "https://doi.org/10.1136/heartjnl-2016-310540" @default.
• W2570786987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28069637" @default.
• W2570786987 hasPublicationYear "2017" @default.
• W2570786987 type Work @default.
• W2570786987 sameAs 2570786987 @default.
• W2570786987 citedByCount "17" @default.
• W2570786987 countsByYear W25707869872017 @default.
• W2570786987 countsByYear W25707869872018 @default.
• W2570786987 countsByYear W25707869872019 @default.
• W2570786987 countsByYear W25707869872020 @default.
• W2570786987 countsByYear W25707869872021 @default.
• W2570786987 countsByYear W25707869872022 @default.
• W2570786987 countsByYear W25707869872023 @default.
• W2570786987 crossrefType "journal-article" @default.
• W2570786987 hasAuthorship W2570786987A5023346746 @default.
• W2570786987 hasAuthorship W2570786987A5059846687 @default.
• W2570786987 hasConcept C126322002 @default.
• W2570786987 hasConcept C164705383 @default.
• W2570786987 hasConcept C177713679 @default.
• W2570786987 hasConcept C2779134260 @default.
• W2570786987 hasConcept C2779161974 @default.
• W2570786987 hasConcept C3019040382 @default.
• W2570786987 hasConcept C71924100 @default.
• W2570786987 hasConceptScore W2570786987C126322002 @default.
• W2570786987 hasConceptScore W2570786987C164705383 @default.
• W2570786987 hasConceptScore W2570786987C177713679 @default.
• W2570786987 hasConceptScore W2570786987C2779134260 @default.
• W2570786987 hasConceptScore W2570786987C2779161974 @default.
• W2570786987 hasConceptScore W2570786987C3019040382 @default.
• W2570786987 hasConceptScore W2570786987C71924100 @default.
• W2570786987 hasIssue "11" @default.
• W2570786987 hasLocation W25707869871 @default.
• W2570786987 hasLocation W25707869872 @default.
• W2570786987 hasOpenAccess W2570786987 @default.
• W2570786987 hasPrimaryLocation W25707869871 @default.
• W2570786987 hasRelatedWork W1540807578 @default.
• W2570786987 hasRelatedWork W1839838842 @default.
• W2570786987 hasRelatedWork W1967841144 @default.
• W2570786987 hasRelatedWork W2018480046 @default.
• W2570786987 hasRelatedWork W2064495796 @default.
• W2570786987 hasRelatedWork W2319489406 @default.
• W2570786987 hasRelatedWork W2333279585 @default.
• W2570786987 hasRelatedWork W2603808924 @default.
• W2570786987 hasRelatedWork W2763816051 @default.
• W2570786987 hasRelatedWork W2889073610 @default.
• W2570786987 hasVolume "103" @default.
• W2570786987 isParatext "false" @default.
• W2570786987 isRetracted "false" @default.
• W2570786987 magId "2570786987" @default.
• W2570786987 workType "article" @default.